Latest Latent autoimmune diabetes Stories
Endocrine Society launches website for primary care physicians on applying new insights into the role of beta-cells in type 2 diabetes to clinical practiceA new consensus statement published in the September, 2010, issue of The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) finds that the increasing recognition that beta-cell failure occurs much earlier and severely than commonly believed suggests that regular glycemia screening, early identification of patients...
Diabetes is the leading reason for kidney failure in the world, resulting in patients requiring dialysis or kidney transplantation. New research has found a cell in the kidney called the podocyte could be the key to understanding why this happens.The study led by Dr Richard Coward, in the School of Clinical Sciences at the University of Bristol, is published in Cell Metabolism and funded by the Medical Research Council (MRC).Diabetes related kidney disease has previously been thought to be...
Findings unchanged after adjustment for obesity and other diabetes risk factors BOSTON, Sept. 29 /PRNewswire-USNewswire/ -- A national epidemiologic study finds a strong, consistent correlation between adult diabetes and particulate air pollution that persists after adjustment for other risk factors like obesity and ethnicity, report researchers from Children's Hospital Boston. The relationship was seen even at exposure levels below the current EPA safety limit. The report, published in the...
TARRYTOWN, N.Y., Sept. 23 /PRNewswire/ -- According to a new study, people with diabetes, especially those treated with insulin, may achieve optimal blood sugar control when they understand the impact of food on blood sugar and they utilize useful advanced blood glucose meter (BGM) features such as meal markers and audible reminders. These findings, presented at the 46th European Association for the Study of Diabetes (EASD) Annual Meeting in Stockholm, Sweden, are important because...
STOCKHOLM, Sept. 23 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the presentation of preclinical research describing the mechanism of action of otelixizumab at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD). In addition, Tolerx also announced that the first European patient was enrolled in DEFEND-2, a confirmatory Phase 3...
WORCESTER, Mass., Sept. 22 /PRNewswire/ -- Generex Biotechnology Corporation (Nasdaq: GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it is presenting study results at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD, www.easd.org) being held in Stockholm, Sweden, 20 - 24 September, 2010 (www.easd2010.com). An abstract entitled No Generation of Insulin Antibodies in...
MOUNTAIN VIEW, Calif., Sept. 21 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it reported positive preclinical and Phase I study results at the European Association for the Study of Diabetes (EASD). CCX140, a novel, orally bioavailable small molecule antagonist of the chemokine receptor CCR2, improved metabolic function while significantly reducing inflammatory macrophages found in adipose tissue in an animal model, and was well tolerated in Phase I clinical trials. These data...
BRIDGEWATER, N.J., Sept. 21 /PRNewswire/ -- Actor Paul Sorvino, living with type 2 diabetes, and his daughter, Academy-award winning actress Mira Sorvino, have teamed up with sanofi-aventis U.S. to launch "Diabetes Co-Stars," an awareness program aimed to help people living with diabetes and those who support them. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/sanofi-aventis/45550/ "'Diabetes Co-Stars' will help inspire people...
JERUSALEM, September 14, 2010 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced today successful results in an exploratory clinical trial testing the effectiveness of its oral insulin capsule (ORMD-0801) in Type I diabetes patients suffering from uncontrolled diabetes. In parallel to Oramed's main focus in developing an oral insulin capsule for management of Type II diabetes the company is exploring an application of its oral insulin capsule toward...
Older adults with diabetes who have high blood pressure, walk slowly or lose their balance, or believe they're in bad health, are significantly more likely to have weaker memory and slower, more rigid cognitive processing than those without these problems, according to a new study published by the American Psychological Association.These three health factors stood out from more than a dozen suspected to shape how Type 2 diabetes is frequently shadowed by cognitive impairment, including...
